© Pint of Science, 2022. All rights reserved.
Researchers developing new treatments for children with rare brain tumours know that it’s not a case of treating children like tiny adults and that surviving the disease isn’t enough. Reducing the damage done by treatments is just as important to the survivor. Discover how researchers are minimising damage and why they think studying rare children’s tumours is vital to our wider understanding.
Are rare tumours worth studying?
Sigourney Bell (Graduate Researcher)
Why is it important that we study paediatric tumours and how are they different to adult cancers? What does the future look like for rare paediatric brain tumours and how can we work towards a better future for these children?
Curing with Kindness - New therapies for curable rare brain tumours
Dr Jessica Taylor (Postdoctoral Associate)
I work at CRUK Cambridge Institute finding new therapies for children with a rare, yet curable brain tumour. However, a cure isn’t enough for these children. After surgery, radiation and aggressive chemotherapy mean that they suffer from a multitude of different side-effects, both short-term and long lasting. We aim to find cures that focus not only on surviving cancer, but on the survivor.